ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.

Kian Keong Poh, Huay Cheem Tan, James Yip, Yean Teng LimPubMed 2005

Abstract

Abxicimab was uncommonly used among patients (9.4 percent) undergoing PCI in this Asian region, with the operators reserving it mainly for high-risk patients.
BibTeX
@inproceedings{poh2005reopro,
  author = {Kian Keong Poh and Huay Cheem Tan and James Yip and Yean Teng Lim},
  title = {{ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.}},
  booktitle = {PubMed},
  year = {2005},
}

Loading related content...

Figure